Rhumbline Advisers Spectrum Pharmaceuticals Inc Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	BUY	$0.65 - $1.31 $2,340 - $4,716	3,600 New	3,600 $3,000
Q2 2022 Aug 11, 2022	SELL	$0.7 - $1.4 $114,093 - $228,187	-162,991 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$0.63 - $1.59 $158,637 - $400,371	-251,806 Reduced 60.71%	162,991 $210,000
Q4 2021 Feb 10, 2022	BUY	$1.27 - $2.42 $13,028 - $24,826	10,259 Added 2.54%	414,797 $527,000
Q3 2021 Nov 12, 2021	SELL	$2.15 - $3.82 $98,925 - $175,765	-46,012 Reduced 10.21%	404,538 $882,000
Q2 2021 Aug 05, 2021	SELL	$2.89 - $4.45 $154,236 - $237,492	-53,369 Reduced 10.59%	450,550 $1.69 Million
Q1 2021 May 06, 2021	BUY	$2.9 - $4.09 $33,176 - $46,789	11,440 Added 2.32%	503,919 $1.64 Million
Q4 2020 Feb 10, 2021	BUY	$3.38 - $5.14 $220,565 - $335,415	65,256 Added 15.27%	492,479 $1.68 Million
Q3 2020 Nov 12, 2020	BUY	$2.99 - $4.9 $123,319 - $202,095	41,244 Added 10.69%	427,223 $1.74 Million
Q2 2020 Aug 13, 2020	BUY	$2.11 - $3.38 $16,795 - $26,904	7,960 Added 2.11%	385,979 $1.31 Million
Q1 2020 May 06, 2020	BUY	$1.83 - $3.45 $33,558 - $63,266	18,338 Added 5.1%	378,019 $881,000
Q4 2019 Feb 05, 2020	BUY	$3.5 - $10.35 $83,041 - $245,564	23,726 Added 7.06%	359,681 $1.31 Million
Q3 2019 Oct 23, 2019	BUY	$7.03 - $9.7 $128,395 - $177,160	18,264 Added 5.75%	335,955 $2.79 Million
Q2 2019 Aug 14, 2019	BUY	$7.36 - $11.26 $162,619 - $248,789	22,095 Added 7.47%	317,691 $2.74 Million
Q1 2019 May 01, 2019	BUY	$9.08 - $11.84 $53,308 - $69,512	5,871 Added 2.03%	295,596 $3.16 Million
Q4 2018 Jan 31, 2019	BUY	$6.39 - $16.99 $360,849 - $959,442	56,471 Added 24.21%	289,725 $2.54 Million
Q3 2018 Nov 07, 2018	BUY	$16.52 - $24.82 $39,152 - $58,823	2,370 Added 1.03%	233,254 $3.92 Million
Q2 2018 Aug 06, 2018	BUY	$14.31 - $21.75 $197,649 - $300,411	13,812 Added 6.36%	230,884 $4.84 Million
Q1 2018 May 02, 2018	BUY	$16.09 - $23.07 $103,458 - $148,340	6,430 Added 3.05%	217,072 $3.49 Million
Q4 2017 Feb 09, 2018	BUY	$13.36 - $20.73 $624,686 - $969,293	46,758 Added 28.53%	210,642 $3.99 Million
Q3 2017 Nov 06, 2017	BUY	$8.75 - $14.07 $1.43 Million - $2.31 Million	163,884	163,884 $2.31 Million

Others Institutions Holding SPPI

# of Institutions

Shares Held

115K

Call Options Held

Put Options Held

Tekla Capital Management LLC

115K
Shares

$0
0.0% of portfolio

View Full List

About SPECTRUM PHARMACEUTICALS INC

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

More about SPPI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account